Site Members can sign up for company wide alerts
Lawsuit Overview
February 21, 2014 (Shareholders Foundation) - An investor who currently holds shares of Cadence Pharmaceuticals, Inc. (NASDAQ:CADX) filed a lawsuit in effort to halt the proposed takeover of Cadence Pharmaceuticals, Inc. by Mallinckrodt plc for $14.00 per share. The plaintiff alleges that the defendants breached their fiduciary duties owed to NASDAQ:CADX stockholders arising out of t...
You must register (for free) or login to view the entire case.